SINOVA-M-14023 Follicle-Stimulating Hormone (FSH) Quantitative Test Kit
Clinical Significance:
- Increased Levels: Observed in testicular seminoma, Klinefelter syndrome, Turner syndrome, primary amenorrhea, castration, post-adrenal corticosteroid treatment, primary gonadal insufficiency, early hyperfunction of the anterior pituitary, and giant cell degenerative lung cancer with ectopic secretion of gonadal substances.
- Decreased Levels: Observed in estrogen therapy, progesterone therapy, secondary gonadal insufficiency, Sheehan's syndrome, and late-stage hypofunction of the anterior pituitary.
Product Specifications: 20 tests/box
Product Shelf Life: 18 months when sealed in an aluminum foil pouch. Use within 1 hour after opening the pouch.
Product Storage: Store the test card at 2℃-30℃.
Usage Scenarios:
- Hospitals and Clinics: For diagnosing and monitoring conditions with altered hormone levels, such as testicular seminoma, Klinefelter syndrome, Turner syndrome, primary amenorrhea, and gonadal insufficiency.
- Endocrinology and Oncology Departments: To assess and monitor endocrine and gonadal function, and diagnose ectopic hormone secretion in cancers.
- Diagnostic Laboratories: For routine hormone level testing in various clinical conditions.
Suitable Countries and Regions:
- Developed Countries: United States, Canada, Western Europe (e.g., Germany, France, UK), Japan, Australia, etc.
- Emerging Markets: China, India, Southeast Asia, Latin America, Eastern Europe, Middle East, etc.
- Global Health Programs: International health initiatives focused on endocrine and reproductive health in low-resource settings.
